Effect of Rebound Pain on Postoperative Intensive Care Delirium in Patients Undergoing Hip Surgery With Peripheral Nerve Block
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Peripheral nerve block applied, Only multimodal analgesia applied.
- Who it may be relevant to
- Registry conditions: Rebound Pain Impact After Hip Surgery With Nerve Block. Basic parameters: 18 years — 80 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Effect of Rebound Pain on Postoperative Intensive Care Delirium in Patients Undergoing Hip Surgery With Peripheral Nerve Block: A Prospective Observational Study
Overview
Postoperative delirium is a significant and commonly encountered complication in patients undergoing hip surgery, particularly among the elderly. Postoperative delirium is associated with serious consequences, including prolonged intensive care unit stay, increased complication rates, higher mortality risk, and rising healthcare costs. The incidence of Postoperative delirium after hip fracture surgery has been reported to range between 13% and 55.9%, indicating a substantial clinical burden. Effective postoperative pain control is critical not only for maintaining quality of life but also for preserving cognitive well-being. In this context, peripheral nerve blocks are frequently used for pain management following hip surgery.
Detailed description
Postoperative delirium is a significant and commonly encountered complication in patients undergoing hip surgery, particularly among the elderly. Postoperative delirium is associated with serious consequences, including prolonged intensive care unit stay, increased complication rates, higher mortality risk, and rising healthcare costs.
The incidence of Postoperative delirium after hip fracture surgery has been reported to range between 13% and 55.9%, indicating a substantial clinical burden.
Effective postoperative pain control is critical not only for maintaining quality of life but also for preserving cognitive well-being. In this context, peripheral nerve blocks are frequently used for pain management following hip surgery.
In recent years, the Pericapsular Nerve Group block and the supra-inguinal fascia iliaca block have gained attention as regional anesthesia techniques that provide effective analgesia by targeting the nerve branches innervating the anterior capsule of the hip joint.
Interventions
- Other Peripheral nerve block applied
Pericapsular Nerve Group block and the supra-inguinal fascia iliaca block applied - Other Only multimodal analgesia applied
Postoperative analgesia (paracetamol 1000 mg intravenously every 8 hours and celecoxib 200 mg orally every 12 hours)
Primary outcome measures
- Incidence of delirium [Time frame: 72 hours]
Eligibility criteria
Inclusion criteria
- Patients aged 18-80
- ASA I-III risk groups
- Undergoing elective hip surgery
Exclusion criteria
- Preoperative history of delirium, dementia, or major neurological disease
- Present cognitive impairment or severe hearing or visual impairment that could affect pain assessment
- Development of mechanical ventilation requirement in the intensive care unit; Need for bilateral hip surgery
- Failure to provide meaningful analgesia after block application due to surgical pain outside the scope of the block
- Patient's inability to complete the pain diary during postoperative follow-up;
- Urgent hip surgery
- Voluntary failure to give consent or request to withdraw from the study.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-control
Study locations
Turkey (Türkiye) · 1 center
- Konya City Hospital — Konya
Identifiers
NCT: NCT07295184 · Rebound pain